Exploring Dual-Targeted Therapy in the Management of Moderate to Severe Inflammatory Bowel Disease: A Retrospective Study

被引：0

作者：

Bhaskar, Sonya ^{[1
]}

Makovich, Zachary ^{[2
]}

Coughlin, Emily ^{[1
]}

Mhaskar, Rahul ^{[1
]}

Seminerio, Jennifer L. ^{[2
]}

机构：

[1] Univ S Florida, Tampa, FL USA

[2] Univ S Florida, Morsani Coll Med, Tampa, FL USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期

关键词：

D O I：

10.14309/01.ajg.0001034136.41707.fa

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1192

引用

页码：S847 / S847

页数：1

共 50 条

[21] Dual-targeted therapy with Certolizumab and Risankizumab for the treatment of Crohn's disease and spondylarthritis
Lehmann, Anouk
Niess, Jan Hendrik
SWISS MEDICAL WEEKLY, 2023, 153 : 29S - 30S
[22] Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease
Miyatani, Yusuke
Choi, David
Choi, Natalie K.
Rubin, David T.
DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (02) : 355 - 359
[23] Interleukin 2 targeted therapy in inflammatory bowel disease
Yarkoni, S.
Sagiv, Y.
Kaminitz, A.
Askenasy, N.
GUT, 2009, 58 (12) : 1705 - 1706
[24] Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Gomez-Labrador, Celia
Ricart, Elena
Iborra, Marisa
Iglesias, Eva
Martin-Arranz, Maria Dolores
de Castro, Luisa
De Francisco, Ruth
Garcia-Alonso, Francisco Javier
Sanahuja, Ana
Gargallo-Puyuelo, Carla J.
Mesonero, Francisco
Casanova, Maria Jose
Manosa, Miriam
Rivero, Montserrat
Calvo, Marta
Sierra-Ausin, Monica
Gonzalez-Munoza, Carlos
Calvet, Xavier
Garcia-Lopez, Santiago
Guardiola, Jordi
Garcia, Lara Arias
Marquez-Mosquera, Lucia
Gutierrez, Ana
Zabana, Yamile
Navarro-Llavat, Merce
Poyatos, Rufo Lorente
Piqueras, Marta
Torrealba, Leyanira
Bermejo, Fernando
Ponferrada-Diaz, Angel
Perez-Calle, Jose L.
Barreiro-de Acosta, Manuel
Tejido, Coral
Cabriada, Jose Luis
Marin-Jimenez, Ignacio
Roncero, Oscar
Ber, Yolanda
Fernandez-Salazar, Luis
Aler, Blau Camps
Lucendo, Alfredo J.
Llao, Jordina
Bujanda, Luis
Villafranca, Carmen Munoz
Domenech, Eugeni
Chaparro, Maria
Gisbert, Javier P.
PHARMACEUTICS, 2024, 16 (05)
[25] Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn’s Disease
Yusuke Miyatani
David Choi
Natalie K. Choi
David T. Rubin
Digestive Diseases and Sciences, 2024, 69 : 355 - 359
[26] A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease
Zhao, Dongju
Tang, Yuqing
Suo, Xinjun
Zhang, Chaonan
Dou, Yan
Chang, Jin
INNOVATION, 2021, 2 (04):
[27] Engineered Probiotics Enable Targeted Gut Delivery of Dual Gasotransmitters for Inflammatory Bowel Disease Therapy
Ma, Tengfei
Gan, Guihai
Cheng, Jian
Shen, Zhiqiang
Zhang, Guoying
Liu, Shiyong
Hu, Jinming
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025,
[28] A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer
Zhang, Yuan
Gu, Wei
Chen, Wan
Zhu, Jieli
Fan, Longfei
Zhang, Liwen
Zhao, Liangyou
Miao, Qingqing
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2025, 147 (09) : 7897 - 7907
[29] Exploring the Link Between Ankylosing Spondylitis and Inflammatory Bowel Disease: A Retrospective Cohort Study
Sharif, Kassem
Lahat, Adi
Shneor, Yonatan
Ben-Shabat, Niv
Omar, Mahmud
Watad, Abdulla
Amital, Howard
Gendelman, Omer
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2024, 26 (04): : 226 - 231
[30] Combination therapy in inflammatory bowel disease - from traditional immunosuppressors towards the new paradigm of dual targeted therapy
Privitera, Giuseppe
Pugliese, Daniela
Onali, Sara
Petito, Valentina
Scaldaferri, Franco
Gasbarrini, Antonio
Danese, Silvio
Armuzzi, Alessandro
AUTOIMMUNITY REVIEWS, 2021, 20 (06)

← 1 2 3 4 5 →